Need to Introduce the Finding of Obesity or Normal Body Weight in the Current Diagnostic Criteria and in the Classification of PCOS
- PMID: 36292244
- PMCID: PMC9601283
- DOI: 10.3390/diagnostics12102555
Need to Introduce the Finding of Obesity or Normal Body Weight in the Current Diagnostic Criteria and in the Classification of PCOS
Abstract
The diagnosis of PCOS is based on the Rotterdam guidelines: chronic anovulation, hyperandrogenism (biologic or clinical) and polycystic ovaries on ultrasound. Two of these three criteria are sufficient for making diagnosis of PCOS. However, one characteristic that is often associated to PCOS (obesity with severe insulin resistance and metabolic alteration regarding glucose metabolism and lipid pattern) has remained out of the current classification of PCOS. Because of this, patients with different metabolic and cardiovascular risk may be included in the same phenotype, and it makes more difficult to establish clear strategies of follow-up and treatment of the patients with increased risks, and also may hide genetic or environmental differences between PCOS patients. Our recent study has shown that metabolic alterations are linked to the weight and not to the Rotterdam phenotypes. Because of this, we suggest a new classification of PCOS phenotypes that divides each Rotterdam phenotype in obese (ob) or lean (l) sub-phenotype. An improved classification of PCOS may be essential for permitting new progress in our understanding of pathogenesis and treatment of PCOS (or of the different disorders that are part of PCOS).
Keywords: PCOS; PCOS phenotypes; insulin resistance in PCOS; lean PCOS; obese PCOS.
Conflict of interest statement
The author declares no conflict of interests.
Similar articles
-
The Prevalence of Polycystic Ovary Syndrome, Its Phenotypes and Cardio-Metabolic Features in a Community Sample of Iranian Population: Tehran Lipid and Glucose Study.Front Endocrinol (Lausanne). 2022 Mar 1;13:825528. doi: 10.3389/fendo.2022.825528. eCollection 2022. Front Endocrinol (Lausanne). 2022. PMID: 35299965 Free PMC article.
-
Comparing Lean and Obese PCOS in Different PCOS Phenotypes: Evidence That the Body Weight Is More Important than the Rotterdam Phenotype in Influencing the Metabolic Status.Diagnostics (Basel). 2022 Sep 25;12(10):2313. doi: 10.3390/diagnostics12102313. Diagnostics (Basel). 2022. PMID: 36292002 Free PMC article.
-
Controversy in clinical endocrinology: diagnosis of polycystic ovarian syndrome: the Rotterdam criteria are premature.J Clin Endocrinol Metab. 2006 Mar;91(3):781-5. doi: 10.1210/jc.2005-2153. Epub 2006 Jan 17. J Clin Endocrinol Metab. 2006. PMID: 16418211
-
Cardiometabolic abnormalities in the polycystic ovary syndrome: pharmacotherapeutic insights.Pharmacol Ther. 2008 Sep;119(3):223-41. doi: 10.1016/j.pharmthera.2008.04.009. Epub 2008 Jun 17. Pharmacol Ther. 2008. PMID: 18602948 Review.
-
AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS, AMERICAN COLLEGE OF ENDOCRINOLOGY, AND ANDROGEN EXCESS AND PCOS SOCIETY DISEASE STATE CLINICAL REVIEW: GUIDE TO THE BEST PRACTICES IN THE EVALUATION AND TREATMENT OF POLYCYSTIC OVARY SYNDROME - PART 2.Endocr Pract. 2015 Dec;21(12):1415-26. doi: 10.4158/EP15748.DSCPT2. Endocr Pract. 2015. PMID: 26642102 Review.
Cited by
-
Is polycystic ovary syndrome associated with elevated muscle sympathetic nerve activity?Exp Physiol. 2023 Oct;108(10):1250-1256. doi: 10.1113/EP091216. Epub 2023 Aug 29. Exp Physiol. 2023. PMID: 37642329 Free PMC article. Review.
-
Endocrine Disrupting Chemicals in Polycystic Ovary Syndrome: The Relevant Role of the Theca and Granulosa Cells in the Pathogenesis of the Ovarian Dysfunction.Cells. 2022 Dec 31;12(1):174. doi: 10.3390/cells12010174. Cells. 2022. PMID: 36611967 Free PMC article. Review.
-
Androgens and Hirsutism in a Large Cohort of Portuguese Women.J Clin Med. 2025 Jan 21;14(3):673. doi: 10.3390/jcm14030673. J Clin Med. 2025. PMID: 39941345 Free PMC article.
-
Global trends in polycystic ovarian syndrome over 30 years: an age-period-cohort study of 204 countries and territories (1990-2021).J Health Popul Nutr. 2025 Jul 8;44(1):242. doi: 10.1186/s41043-025-01002-1. J Health Popul Nutr. 2025. PMID: 40629416 Free PMC article.
-
The Role of Gene Alterations in the Pathogenesis of Polycystic Ovary Syndrome.J Clin Med. 2025 May 12;14(10):3347. doi: 10.3390/jcm14103347. J Clin Med. 2025. PMID: 40429342 Free PMC article. Review.
References
-
- Teede H.J., Misso M.L., Costello M.F., Dokras A., Laven J., Moran L., Piltonen T., Norman R.J., International PCOS Network Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome. Fertil. Steril. 2018;110:364–379. doi: 10.1016/j.fertnstert.2018.05.004. - DOI - PMC - PubMed
LinkOut - more resources
Full Text Sources
Miscellaneous